Tumors exhibiting desmoplasia and lymph node metastasis (≥50%) demonstrated high DLL3 expression, whereas non-desmoplastic specimens showed low DLL3 levels. The gene discussed is DLL3; the disease is metastatic malignant neoplasm in the lymph nodes.